# PDS Biotechnology Corp: Form 8-K, filed May 1, 2026

- Company: [PDS Biotechnology Corp](/companies/pdsb.md) (CIK 1472091)
- Form: 8-K
- Filed: 2026-05-01
- Accepted by EDGAR: May 1, 2026, 16:26 ET
- Period: 2026-04-30
- Accession: 0001140361-26-018464
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/ef20072168_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/ef20072168_8k.htm

Filed May 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-018464. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.